Benefits and risks of endovascular treatment in patients with proximal vertebral artery stenosis

S. Babić, Mihajlo Nešković, S. Tanasković, D. Sagic, Ž. Antonić, P. Popov, D. Unić-Stojanović, P. Gajin, P. Matic, Đ. Radak
{"title":"Benefits and risks of endovascular treatment in patients with proximal vertebral artery stenosis","authors":"S. Babić, Mihajlo Nešković, S. Tanasković, D. Sagic, Ž. Antonić, P. Popov, D. Unić-Stojanović, P. Gajin, P. Matic, Đ. Radak","doi":"10.5937/medist1503038b","DOIUrl":null,"url":null,"abstract":"Extracranial vertebral artery stenosis is an important cause of posterior circulation ischemic stroke. There are several therapeutic approaches in patients with vertebral artery (VA) stenosis, including medical, endovascular and surgical treatment. This review should summarize the literature concerning endovascular treatment (EVT) of extracranial VA stenosis. By scanning reference lists of other review articles and by searching electronic database MEDLINE by using major MESH term \"vertebrobasilar insufficiency/therapy\" from January 2010 to April 2015, studies that included patients of any race, age and sex with symptomatic or asymptomatic atherosclerotic stenotic VA disease were identified. Periprocedural transitory ischemic attack (TIA) and stroke, and death within 30 days of the treatment were our primary interest and symptom resolution was secondary outcome measure. We found 12 retrospective studies with prospectively collected data and one additional comparative study of VA angioplasty/stenting and medical treatment was found. Percutaneous luminal angioplasty or stenting alone, or their combinations were performed in 693 patients (726 lesions). Periprocedural TIA or stroke occurred in 14 out of 693 patients (2.0%) and 30 days mortality in 1 (0.15%). A wide range of restenosis rates (3-58%) was reported. The literature shows that EVT of extracranial VA stenosis is safe and efficient. The vast majority of patients remain symptom free after the procedure, despite the restenosis rate.","PeriodicalId":167411,"journal":{"name":"Medicinska istrazivanja","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinska istrazivanja","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/medist1503038b","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Extracranial vertebral artery stenosis is an important cause of posterior circulation ischemic stroke. There are several therapeutic approaches in patients with vertebral artery (VA) stenosis, including medical, endovascular and surgical treatment. This review should summarize the literature concerning endovascular treatment (EVT) of extracranial VA stenosis. By scanning reference lists of other review articles and by searching electronic database MEDLINE by using major MESH term "vertebrobasilar insufficiency/therapy" from January 2010 to April 2015, studies that included patients of any race, age and sex with symptomatic or asymptomatic atherosclerotic stenotic VA disease were identified. Periprocedural transitory ischemic attack (TIA) and stroke, and death within 30 days of the treatment were our primary interest and symptom resolution was secondary outcome measure. We found 12 retrospective studies with prospectively collected data and one additional comparative study of VA angioplasty/stenting and medical treatment was found. Percutaneous luminal angioplasty or stenting alone, or their combinations were performed in 693 patients (726 lesions). Periprocedural TIA or stroke occurred in 14 out of 693 patients (2.0%) and 30 days mortality in 1 (0.15%). A wide range of restenosis rates (3-58%) was reported. The literature shows that EVT of extracranial VA stenosis is safe and efficient. The vast majority of patients remain symptom free after the procedure, despite the restenosis rate.
椎动脉近端狭窄患者血管内治疗的益处和风险
颅外椎动脉狭窄是后循环缺血性脑卒中的重要病因。椎动脉(VA)狭窄有几种治疗方法,包括药物治疗、血管内治疗和手术治疗。本文综述了有关颅内外室内外动脉狭窄的血管内治疗的文献。通过扫描2010年1月至2015年4月的其他综述文章的参考文献列表,并使用主要MESH术语“椎基底动脉功能不全/治疗”搜索MEDLINE电子数据库,确定了包括任何种族、年龄和性别的有症状或无症状的动脉粥样硬化性狭窄性VA疾病患者的研究。围手术期短暂性脑缺血发作(TIA)和卒中,以及治疗后30天内死亡是我们的主要研究目标,症状缓解是次要结局指标。我们发现了12项前瞻性收集数据的回顾性研究,并发现了一项额外的VA血管成形术/支架植入与药物治疗的比较研究。693例患者(726个病变)接受了经皮腔内血管成形术或支架置入术,或两者联合。693例患者中有14例(2.0%)发生围手术期TIA或卒中,1例(0.15%)30天死亡。有广泛的再狭窄发生率(3-58%)的报道。文献表明,EVT治疗颅外VA狭窄是安全有效的。尽管再狭窄率高,但绝大多数患者在手术后仍无症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信